Sale!

BCL9L Gene Heterotaxy Visceral BCL9L Related NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The BCL9L Gene Heterotaxy Visceral NGS Genetic DNA Test is a comprehensive genetic analysis that identifies mutations in the BCL9L gene associated with heterotaxy syndrome, a rare congenital disorder affecting organ positioning. This advanced next-generation sequencing test provides crucial diagnostic information for individuals with abnormal organ arrangement, particularly affecting heart, liver, spleen, and lung positioning. The test helps confirm genetic causes of heterotaxy, guides treatment decisions, and provides essential information for family planning. With results available in 3-4 weeks and requiring only a blood sample or extracted DNA, this $500 test offers valuable insights for patients and families affected by this complex condition. Genetic counseling is recommended before testing to understand implications and create family pedigree charts.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

BCL9L Gene Heterotaxy Visceral BCL9L Related NGS Genetic DNA Test

Comprehensive Genetic Analysis for Organ Positioning Disorders

The BCL9L Gene Heterotaxy Visceral NGS Genetic DNA Test represents a cutting-edge diagnostic tool for identifying genetic mutations responsible for heterotaxy syndrome, a rare congenital condition characterized by abnormal arrangement of internal organs. This sophisticated genetic test utilizes next-generation sequencing technology to provide precise detection of BCL9L gene variations that disrupt normal left-right body axis development during embryonic growth.

What Does This Test Measure and Detect?

This comprehensive genetic analysis specifically targets the BCL9L gene, which plays a crucial role in the Wnt signaling pathway essential for proper organ positioning and development. The test detects:

  • Point mutations in the BCL9L gene coding regions
  • Small insertions and deletions affecting gene function
  • Copy number variations impacting gene dosage
  • Pathogenic variants associated with heterotaxy spectrum disorders
  • Genetic markers influencing organ laterality and positioning

Who Should Consider This Genetic Test?

This test is particularly recommended for individuals presenting with symptoms or clinical features suggestive of heterotaxy syndrome:

  • Newborns and children with congenital heart defects involving abnormal chamber positioning
  • Patients with abnormal spleen development or asplenia/polysplenia
  • Individuals with midline organ abnormalities or situs inversus
  • Those with complex cardiac anomalies requiring surgical intervention
  • Patients with family history of heterotaxy or congenital heart defects
  • Individuals undergoing evaluation for unexplained developmental abnormalities

Clinical Benefits of BCL9L Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous clinical advantages:

  • Accurate Diagnosis: Confirms genetic basis for heterotaxy symptoms
  • Treatment Guidance: Informs surgical planning and medical management
  • Prognostic Information: Helps predict disease progression and complications
  • Family Planning: Provides recurrence risk information for future pregnancies
  • Early Intervention: Enables timely management of associated conditions
  • Comprehensive Care: Facilitates multidisciplinary approach to treatment

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our expert geneticists and presented with comprehensive clinical context:

  • Positive Result: Indicates presence of pathogenic BCL9L mutation confirming genetic diagnosis
  • Negative Result: Suggests absence of detected BCL9L mutations but doesn’t rule out other genetic causes
  • Variant of Uncertain Significance: Requires additional family studies for interpretation
  • Carrier Status: Identifies individuals with single copy mutations who may pass condition to offspring

All results include detailed explanations and recommendations for follow-up care, with genetic counseling available to help understand implications for you and your family.

Test Specifications and Pricing

Test Component Details
Test Name BCL9L Gene Heterotaxy Visceral BCL9L Related NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood or Extracted DNA or One drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology
Specialty Pediatrics, Genetics
Disease Category Dysmorphology

Pre-Test Requirements and Preparation

Before scheduling your BCL9L genetic test, we recommend:

  • Complete clinical history documentation of the patient
  • Genetic counseling session to discuss test implications
  • Creation of detailed family pedigree chart
  • Review of previous diagnostic studies and imaging
  • Discussion of potential outcomes and management options

Nationwide Testing Availability

We proudly offer comprehensive genetic testing services across the United States with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our state-of-the-art laboratories ensure consistent, high-quality results regardless of your location.

Take the Next Step Toward Genetic Clarity

If you or your loved one is experiencing symptoms suggestive of heterotaxy syndrome or has a family history of congenital organ positioning disorders, the BCL9L Gene Heterotaxy Visceral NGS Genetic DNA Test provides the definitive genetic answers you need. Our expert team is ready to guide you through the testing process and help you understand the implications of your results.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Take control of your genetic health with the precision and expertise of General Genetics Corporation.